Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.1B | 5.1B | 5.3B | 10.2B |
| Cost of revenue | 3.8B | 3.5B | 3.8B | 7.2B |
| Gross profit | 1.3B | 1.6B | 1.5B | 2.9B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 956M | 1.1B | 977M | 1.2B |
| Other operating expenses | 5M | -1M | 184M | — |
| Operating income | 291M | 471M | 265M | 1.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 179M | 212M | 184M | 162M |
| Other income expense | -65M | -74M | -69M | -824M |
| Pretax income | 47M | 202M | 12M | 682M |
| Tax provision | 28M | 84M | -13M | 290M |
| Net income | 19M | 118M | 25M | 392M |
| Basic EPS | 0.0 | 0.2 | 0.0 | 0.8 |
| Diluted EPS | 0.0 | 0.2 | 0.0 | 0.8 |
| Basic average shares | 489.4M | 492.8M | 494.7M | 494.6M |
| Diluted average shares | 489.5M | 492.9M | 494.9M | 494.9M |
| EBITDA | 824M | 1.1B | 858M | 2.2B |
| Net income from continuing op. | 19M | 118M | 25M | 392M |
| Minority interests | -8M | -5M | -7M | -7M |
| Preferred stock dividends | — | — | — | — |